Catch up on the top radiology content of the past week.
|Articles|January 8, 2004
FDA approves R2 CAD
R2 Technology's proprietary mammography CAD has been approved by the FDA for sale with Fischer Imaging's SenoScan TrueView digital mammography system. Fischer plans to integrate R2's ImageChecker technology with SenoScan to support CAD analysis of
Advertisement
R2 Technology's proprietary mammography CAD has been approved by the FDA for sale with Fischer Imaging's SenoScan TrueView digital mammography system. Fischer plans to integrate R2's ImageChecker technology with SenoScan to support CAD analysis of digital mammograms.
Advertisement
Related to this article
Use of the AI-enabled slab technology from reconstructed DBT imaging led to a 7.4-second mean reduction in reading time in a new study involving 391 cases and 15 reviewing radiologists.
A Kaiser score > 5 with breast MRI demonstrated a 97 percent sensitivity and 87.9 percent specificity for predicting malignancy in patients with BI-RADS 0 or 4 presentations on mammography and breast ultrasound, according to a new study.
Catch up on the top radiology content of the past week.
In the latest episode of her Breast Imaging in Focus series, Manisha Bahl, MD, MPH, FSBI, discusses new research comparing mammography-based AI models for breast cancer detection and short-term risk prediction.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
Key Features with EPNI on CT May More than Double Mortality Risk in Pancreatic Cancer
2
Top Five Radiology Content in October 2026
3
Could a CCTA-Guided Approach Provide a Viable Alternative to Intravascular Ultrasound Guidance for PCI Procedures?
4
Is Late Arterial Phase CT Necessary for Undifferentiated Acute Abdominal Pain?
5